Diabetics Get Freedom in Bionic Pancreas Real-World Trial

A bionic pancreas designed to take over blood sugar control in people with type 1 diabetes got patients to near normal levels and prevented dangerous drops better than standard therapy in two demanding five-day trials.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.